cVAD (USPella)

USpella: Impella 2.5, Impella 5.0, Impella LD, and Impella CP Data Registry

November 22, 2017

  • Clinical Trial Information

    Trial Contact: Tinetti, Meghan

    Trial Phone: 321.841.3682

  • IRB No: 11.097.10

    Principal Investigator: Vijaykumar S Kasi, MD

    Age Group: Adult

    Treatment: Chart Review

    Applicable Disease Sites: Heart Failure

  • Objective

    Assess the safety of the technology and develop best practice guidelines for clinical course of patients requiring Impella 2.5, Impella 5.0/LD or Impella CP support.

  • Key Eligibility

    Hemodynamic monitoring